EMILY PAYNE: Open Payments
NPI 1932874104 · SOUTH JORDAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 14 payments from 7 companies in 2025. Trend: 2023 $157 · 2024 $19 · 2025 $274
Food & beverage: $274
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $102 |
| ABBVIE INC. | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Organon LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Boston Scientific Corporation | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
Products named: AIRSUPRA, CAPLYTA, BREZTRI, UBRELVY, QULIPTA, VRAYLAR, NEXPLANON, MOUNJARO.
Industry payments across UT — which companies pay providers there.
